Поисковый запрос: (<.>S=ФАРМАКОКИНЕТИЧЕСКИЕ СВОЙСТВА<.>) |
Общее количество найденных документов : 50
Показаны документы с 1 по 20
|
|
1.
| Samuelsen O.B. A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic halibut, Hippoglossus hipoglossus L., held in sea water at 9 // J. Fish Diseases, 1999. Vol. 22, N 1.-С.13-23
|
2.
| Miseta A szemcseppek biofarmaciaja // Gyogyszereszet, 1989. Vol. 33, N 2.-С.81-84
|
3.
| Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target // Biochim. et biophys. acta. Biomembranes., 1991. Vol. 1062, N 2.-С.142-148
|
4.
| Advances in Drug Delivery Systems // J. Contr. Release, 1990. Vol. 11, N 1-3.-С.1-359
|
5.
| Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes // FEBS Lett, 1990. Vol. 268, N 1.-С.235-237
|
6.
| Ramos Aspectos microbiologicos, farmacocineticos y clinicos de los nuevos macrolidos de 14 y 15 atomos // Enferm. infecc. y microbiol. clin, 1998. Vol. 16, N 10.-С.474-482
|
7.
| Ramos Aspectos microbiologicos, farmacocineticos y clinicos de los nuevos macrolidos de 14 y 15 atomos // Enferm. infecc. y microbiol. clin, 1998. Vol. 16, N 10.-С.474-482
|
8.
| Behavior and physiological effects of supplemental episodes of testosterone, its precursors and metabolite in rats // Life Sci., 1990. Vol. 47, N 21.-С.1965-1971
|
9.
| Characterization of the enhancing effect of a vehicle in a transdermal system // Drug. Dev. and Ind. Pharm., 1989. Vol. 15, N 14-16.-С.2393-2406
|
10.
| Sezaki H. Chemical modification and disposition of proteins and peptides: biopharmaceutical aspects // Int. Pharm. J., 1991. Vol. 5, Suppl..-С.17
|
11.
| Clinical testing of prolonged action forms with special reference to extended release forms // Pharmacol. and Toxicol., 1990. Vol. 68, N 5.-С.449-453
|
12.
| Hiral Colloidal metal dispersion, and a colloidal metal complex
|
13.
| Controlled release implants for cardiovascular disease // J. Contr. Release, 1990. Vol. 4, N 1-3.-С.245-254
|
14.
| Correlation of G.I. transit parameters and pharmacokinetic characteristics of a controlled release nifedipine formulation // Abstr. Pap. 92nd Annu. Meet., San Antonio, Tex., March 13-15, 1991. -Norristown (Pa), 1991.-С.6
|
15.
| Hwang Cysteine S-conjugates may act as kidney-selective prodrugs formation of 6-mercaptopurine by the renal metabolism of S-(6-purinyl)-L-cysteine // J. Pharmacol. and Exp. Ther., 1989. Vol. 251, N 2.-С.448-454
|
16.
| Middleton D.L. Design and evaluation of an ocular bioadhesive delivery system // STP pharma sci., 1991. Vol. 1, N 3.-С.200-206
|
17.
| Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents // J. Biol. Chem., 2004. Vol. 279, N 32.-С.33613-33622
|
18.
| Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents // J. Biol. Chem., 2004. Vol. 279, N 32.-С.33613-33622
|
19.
| In vivo studies of long circulating (Stealth) liposomes in rats // Period. biol., 1991. Vol. 93, N 2.-С.349-352
|
20.
| Bijsterbosch Martin K. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to kupffer cells // Mol. Pharmacol., 1989. Vol. 36, N 3.-С.484-489
|
&uf('+1W2226#',v2226), ?>
|
|